Global Peripheral Stent Implants Market is Likely to Grow at a CAGR Value of 6.7% By 2028

05-Aug-2022 | Zion Market Research

The global peripheral stent implants market size was worth USD 3,291.5 million in 2021 and is estimated to grow to USD 4,857.1 million by 2028, with a compound annual growth rate (CAGR) of roughly 6.7% over the forecast period.

Peripheral artery disease is caused by fatty deposits in the arteries and lowers the blood flow to the muscles. Peripheral vascular illnesses are conditions that affect blood vessels outside of the heart, including those in the brain, stomach, limbs, and kidneys. A synthetic tubular mesh component implanted permanently in the body's natural vasculature is referred to as a vascular stent, also known as an intravascular stent. With the rising frequency of peripheral vascular disorders worldwide, the market for peripheral stent implants is projected to expand.

The global peripheral stent implants market is growing due to rising government & corporate support, and more awareness in underdeveloped & emerging nations, among other factors. Additionally, it is anticipated that technological developments in stents and increased cases of peripheral artery disease would support market demand. With the rising usage of peripheral stents in angioplasty and conventional open surgery, the market for peripheral stent implants is expanding globally. Peripheral stent implants have improved and gained more acceptability due to increased approvals for cutting-edge technologies, including eluting stents and bio-based stents, boosting their availability in Europe, Japan, and the US in the latest years. The global market for peripheral stent implants is growing but is being constrained by the rules placed on them to guarantee patient safety. Nevertheless, opportunities are created for major participants in the peripheral stent implants market by a growing patient base and aging population.

The global peripheral stent implants market is segregated based on product, artery type, end user, and region. Based on product, the market is divided into bare metal stents (BMS), covered stents, and drug-eluting stents (DES). In 2021, the drug-eluting stents (DES) category dominated the global market. Based on artery type, the market is divided into carotid artery stents, fem-pop artery stents, iliac artery stents, and infra-pop artery stents. In 2021, the carotid artery stents category dominated the global market. Based on end-user, the market is divided into hospitals and ambulatory surgical centers/outpatients. In 2021, the hospital’s category dominated the global market.

The global peripheral stent implants market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. With a revenue share of over 32.0% in 2021, North America led the market for peripheral stent implants and is expected to continue on this path in the near future. North America’s peripheral stent implants market is largely driven by a sedentary lifestyle that causes obesity leading to cardiovascular disorders, including heart attack, stroke, ischemic heart disease (IHD), etc. The market growth has also been accelerated by technical developments in the stent technologies, such as drug-eluting stents and the utilization of biodegradable materials. The market expansion in this area is driven by established market players like Medtronic, Abbott, and Boston Scientific. The market for peripheral stent implants in Asia Pacific is anticipated to develop at the quickest rate in terms of revenue. This market is fueled by a number of additional factors, including improved CAD screening, economic expansion, regulatory revisions, and notably favorable reimbursement in select nations like Australia and South Korea.

Key players in the global peripheral stent implants market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cook Medical, Inc., Boston Scientific Corporation, iVascular SLU, Cardinal Health, Inc., Terumo Corporation, Medtronic Plc., and W. L. Gore & Associates Inc.

Recent Development:

  • In May 2021, the Balloon-expanding (BX) covered stent iCover from iVascular acquired CE mark clearance. It is used to treat ruptures and aneurysms and arteriosclerotic lesions in the iliac and renal arteries. The company was able to grow because of this tactic.
  • In December 2020, MicroPort Scientific reported that it had acquired a registration certificate for its Bridge vertebral drug-eluting stent from China's National Medical Products Administration (NMPA). The gadget has a novel drug delivery system that enables quicker endothelialization and lower thromboembolic and restenosis occurrences. The oval strengthens the company's market presence.

Browse the full Peripheral Stent Implants Market By Product (Bare Metal Stents (BMS), Covered Stents, and Drug Eluting Stents (DES)), By Artery Type (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, and Infrapop Artery Stents), By End-User (Hospitals and Ambulatory Surgical Centers/Outpatient), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028. Report at https://www.zionmarketresearch.com/report/peripheral-stent-implants-market

Global Peripheral Stent Implants Market is segmented as follows:

By Product

  • Bare Metal Stents (BMS)
  • Covered Stents
  • Drug-Eluting Stents (DES)

By Artery Type

  • Carotid Artery Stents
  • Fem-Pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

By End-User

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed